Customer Center
Login | Register

Investor Relations

  • Banner Image

News Releases

Date Title  
Toggle Summary Luminex Corporation to Present at the Barclays Global Healthcare Conference
AUSTIN, Texas , March 5, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Barclays Global Healthcare Conference to be held March 12-14, 2019 , in Miami . The fireside chat will begin at 9:30 a.m. Eastern time on Tuesday, March 12, 2019 .
Toggle Summary Luminex Corporation Declares First Quarter Cash Dividend
AUSTIN, Texas , Feb. 8, 2019 /PRNewswire/ --   Luminex Corporation (Nasdaq:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the first quarter of 2019 of $0.06 per share of common stock payable on April 11 , 2019 to stockholders of record as of the
Toggle Summary Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results
AUSTIN, Texas , Feb. 4, 2019 /PRNewswire/ --  Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and full-year 2018.  Financial and operating highlights for the quarter and full-year include: On December 31, 2018 , the Company closed the acquisition of EMD
Toggle Summary Luminex Announces Preliminary Revenue for the Fourth Quarter and Full Year 2018; Company to Present at 37th Annual J.P. Morgan Healthcare Conference
AUSTIN, Texas , Jan. 7, 2019 /PRNewswire/ --  Luminex Corporation (Nasdaq: LMNX) today announced that it expects its revenues in the fourth quarter of 2018 to be approximately $81 million and to exceed $315 million for the full- year ended 2018, near the top of the previously communicated guidance
Toggle Summary Luminex Corporation Completes Acquisition of MilliporeSigma's Flow Cytometry Portfolio
AUSTIN, Texas , Jan. 2, 2019 /PRNewswire/ --  Luminex Corporation (NASDAQ: LMNX) today announced that the company has completed its previously announced acquisition of MilliporeSigma's flow cytometry portfolio for $75 million in combined stock, asset and inventory purchases.
Toggle Summary Luminex Corporation Declares Fourth Quarter Cash Dividend
AUSTIN, Texas , Dec. 11, 2018 /PRNewswire/ --  Luminex Corporation (Nasdaq:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the fourth quarter of 2018 of $0.06 per share of common stock payable on January 10 , 2019 to stockholders of record as of the
Toggle Summary Luminex Corporation Reports Third Quarter 2018 Financial Results
AUSTIN, Texas , Nov. 5, 2018 /PRNewswire/ --  Luminex Corporation (Nasdaq: LMNX) today announced financial results for the third quarter of 2018.  Financial and operating highlights for the quarter include: Third quarter 2018 consolidated revenue was $72.4 million , a decrease of 2% compared to the
Toggle Summary Luminex Corporation to Acquire MilliporeSigma's Flow Cytometry Portfolio
- Strategic Deal Extends and Diversifies Company's Footprint in Life Science Research - Expands Luminex's Flow-based Instrument Offering Into Cellular Analysis with Acquisition of Amnis and Guava Branded Instruments - Transaction Expected to Close by End of 2018 AUSTIN, Texas , Oct.
Toggle Summary Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018
AUSTIN, Texas , Oct. 15, 2018 /PRNewswire/ --  Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the third quarter ended September 30, 2018 on Monday, November 5, 2018 . A press release announcing the results is scheduled for release after the close of trading
Toggle Summary Luminex Corporation Declares Third Quarter Cash Dividend
AUSTIN, Texas , Sept. 11, 2018 /PRNewswire/ --   Luminex Corporation (Nasdaq:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the third quarter of 2018 of $0.06 per share of common stock payable on October 12 , 2018 to stockholders of record as of the